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Abstract
Molecular differences between HLA alleles vary up to 57 nucleotides within the peptide binding coding region of human
Major Histocompatibility Complex (MHC) genes, but it is still unclear whether this variation results from a stochastic process
or from selective constraints related to functional differences among HLA molecules. Although HLA alleles are generally
treated as equidistant molecular units in population genetic studies, DNA sequence diversity among populations is also
crucial to interpret the observed HLA polymorphism. In this study, we used a large dataset of 2,062 DNA sequences defined
for the different HLA alleles to analyze nucleotide diversity of seven HLA genes in 23,500 individuals of about 200
populations spread worldwide. We first analyzed the HLA molecular structure and diversity of these populations in relation
to geographic variation and we further investigated possible departures from selective neutrality through Tajima’s tests and
mismatch distributions. All results were compared to those obtained by classical approaches applied to HLA allele
frequencies. Our study shows that the global patterns of HLA nucleotide diversity among populations are significantly
correlated to geography, although in some specific cases the molecular information reveals unexpected genetic
relationships. At all loci except HLA-DPB1, populations have accumulated a high proportion of very divergent alleles,
suggesting an advantage of heterozygotes expressing molecularly distant HLA molecules (asymmetric overdominant
selection model). However, both different intensities of selection and unequal levels of gene conversion may explain the
heterogeneous mismatch distributions observed among the loci. Also, distinctive patterns of sequence divergence
observed at the HLA-DPB1 locus suggest current neutrality but old selective pressures on this gene. We conclude that HLA
DNA sequences advantageously complement HLA allele frequencies as a source of data used to explore the genetic history
of human populations, and that their analysis allows a more thorough investigation of human MHC molecular evolution.
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Introduction
The Human Leukocyte Antigen (HLA) loci are among the most
polymorphic genes currently described in the human genome,
with more than 4,000 observed alleles according to release 2.27.1
of IMGT/HLA database. These loci are located on the short arm
of chromosome 6 within the Major Histocompatibility Complex
(MHC) and are extensively studied due to their critical role in
organ or hematopoietic stem cell transplantation and clinical
medicine. Allelic variation of HLA genes is characterized at the
DNA sequence level since the mid of 1990s [1,2]. This approach
started with the development of molecular typing methods for class
II loci (e.g. PCR-SSP, direct or reverse PCR-SSO, PCR-SSCP,
and SBT), and more recently for class I loci, HLA-Cw being the
last gene studied with such typing strategies [3,4,5,6,7]. The
characterization and classification of alleles follow strict rules
recommended by the WHO HLA Nomenclature Committee For
Factor of the HLA System [8,9], and make use of a hierarchic
numerical code for allele naming introduced shortly after the 10
th
Histocompatibility Workshop and Conference. The DNA se-
quence of each HLA allele is now accessible to the whole scientific
community through an online database which also provides
genomic and coding sequence alignments for every locus,
nomenclature guidelines, complete listings of alleles and new
allele reports, among other information [8,10].
Despite the availability of such an important amount of data,
thus far the information on HLA nucleotide sequences has been
mainly used to investigate the evolutionary history of the human
MHC [11,12,13,14,15,16,17,18] or to interpret individual HLA
genotypic profiles for clinical (i.e. transplantation) purposes, but it
has seldom been used to study the genetic variation among
populations. Many studies have shown that the HLA polymor-
phism is very informative to reconstruct past human migration
events [19,20,21,22,23,24,25]. However, these works are based on
the interpretation of allelic frequency distributions, with all alleles
being considered as equidistant molecular units in each popula-
tion; the main reason being that there is still a lot of uncertainty
associated to HLA molecular typings due to the extreme level of
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numerous ambiguities which correspond to situations where either
several allelic pairs (i.e. potential genotypes) can explain the
reactivity profile obtained for an individual, or the resolution of the
typing protocol is too low to allow discrimination between some
alleles. As a consequence, establishing a direct relationship
between ‘‘allele names’’ (generally, groups including several
ambiguous alleles) and their corresponding nucleotide sequences
has been very hazardous, preventing the use of the latter in
population studies. Moreover, when a study includes many
population samples that were not characterized by the same
molecular typing methods, the existence of different ambiguity
patterns in different population samples further increases the
complexity of the data.
However, new perspectives have emerged to use the HLA
nucleotide sequence information for anthropological purposes: firstly,
through large scale homogeneous treatments of ambiguous genotypes
in population samples by the International Histocompatibility Working Group
– Anthropology/Human Genetic Diversity (IHWG-AHGD) component of
the 13
th Histocompatibility Workshop and Conference [26]; and
secondly, through the recent development of computer programs (i.e.
Gene[rate] tools at http://geneva.unige.ch/generate/) that implement
powerful methods of allelic frequency estimation on data that contain
genotyping ambiguities [27,28,29,30] within the scope of the Analysis of
HLA Population Data (AHPD) component of the 15
th Histocompatibility
Workshop and Conference [31] and of the HLA-NET European
COST project (http://w3.cost.esf.org/index.php?id=212&action
_number=BM0803).
In this study we analyzed the nucleotide diversity of seven HLA
genes (HLA-A, -B, -Cw, -DPB1, -DQA1, -DQB1, and -DRB1) in
more than 23’500 individuals from about two hundred popula-
tions of all continents (Table 1 and File S1). We first applied an
extensive treatment of the data at the genotypic and nucleotide
levels to ensure compatibility with the latest updates of the official
HLA allele nomenclature. We then analyzed the DNA molecular
variation of HLA at several geographic scales (i.e. worldwide,
continental, and regional) to investigate its congruence with the
observed genetic diversity profiles based on allelic frequencies and
explore the additional information brought by DNA sequences.
Despite the complex evolution of the HLA system and the
difficulty to disentangle the effects of molecular mechanisms such
as balancing selection, gene conversion and recombination, our
results suggest a strong influence of demographic factors and past
human migrations on its DNA polymorphism. Nevertheless,
natural selection acts by maintaining highly divergent alleles
within populations, probably as a consequence of asymmetric
overdominance of heterozygote individuals. Furthermore, ancient
traces of selective pressures were detected in DNA sequences of
HLA-DPB1, a locus whose evolution is usually assumed to be close
to neutral expectations.
Results
Nucleotide diversity and heterozygosity
Expected heterozygosity (h) and nucleotide diversity (pn) within
populations averaged on each geographic region are given in File
S2 and plotted in Figure 1A and 1B, respectively. Values ranged
from 0.525 (HLA-DPB1 in NAM) to 0.961 (HLA-B in NAF) for h,
and from 0.011 (HLA-DPB1 in NAM) to 0.082 (HLA-DQA1 and
-DRB1 in NEA) for pn. For h, HLA-B was the most diversified and
HLA-DPB1 the less diversified locus in almost all regions, but
standard deviations overlapped between loci in many population
groups (results not shown). For pn, on the contrary, a clear-cut
difference appeared between loci, with HLA-DRB1, -DQA1 and -
DQB1 (class II loci) exhibiting higher values than HLA-B, -A, -Cw
(class I loci) and -DPB1 (class II locus) in all but one (SAM)
geographic regions. Reduced diversity values of both pn and h
were observed in aboriginal populations from SEA (i.e. TW), as
well as in PAC, AUS, NAM and SAM compared to EUR, SAF,
NAF, SWA, NEA and CSEA, except for pn at HLA-Cw. This
reflects peculiar demographic histories for Taiwanese aborigines,
Oceanian and Amerindian populations, which most certainly
underwent rapid genetic drift due to small population sizes and
geographic and/or cultural barriers.
Distributions of mean pairwise differences between allele
sequences within populations
Figure 2 shows the distributions of pairwise differences (i.e.
mismatch distributions) between allelic DNA sequences of each
HLA locus averaged on all populations in each geographic region.
The proportion of sequence pairs diverging by 0, 1 to 10, 11 to 20,
21 to 30, 31 to 40, and more than 40 nucleotides is also plotted in
a box at the top-right of each graphic.
HLA-B exhibited the highest number of nucleotide differences
within PBR coding exons, with up to 51 nucleotides diverging
between alleles, followed by HLA-A, -DRB1 and -DQB1 alleles
(up to 38 diverging nucleotides), and HLA-DQA1 (34), -Cw (27)
and -DPB1 (20).
Several peculiarities distinguished one locus from another,
notably for HLA-DPB1 and -DQB1, both described hereafter, or
for HLA-Cw compared to the other two class I loci -A and -B (i.e.
less divergent alleles were observed for HLA-Cw). However, some
similarities also appeared. First, there were higher proportions (up
to twice) of identical allele pairs (i.e. class 0) in AME, PAC and
AUS (and TW, results not shown) than in populations from EUR,
SAF, NAF, SWA, NEA (and CSEA, results not shown). This result
reflects the fact that Amerindian, Oceanian and Taiwanese
aboriginal populations usually exhibited one or two alleles at high
frequencies and only a small number of less frequent ones,
probably as a consequence of rapid genetic drift. As each DNA
sequence present in a population sample is compared to the others
depending on their respective absolute frequency, the presence of
one or two predominant alleles is weighting strongly on the
percentage of pair comparisons included in class 0. By contrast,
European, continental Asian and African populations generally
showed many alleles with more even frequencies. Second, closely
related alleles (,10 diverging nucleotides) were uncommon, while
divergent ones (.20 diverging nucleotides) were abundant within
all population groups, at most loci. This result was very clear for
HLA-A, -B and -DQA1, with averages on all geographic regions
of 57%, 71.6% and 58% of allele pairs differing by more than 20
nucleotides, respectively. HLA-Cw and -DRB1 also showed a
pattern of low relatedness between alleles, but it was less
pronounced (allele pairs differing by more than 20 nucleotides
took values ranging from 8% at HLA-Cw in SAF to 57% at HLA-
DRB1 in EUR, respectively). HLA-DQB1 exhibited a slightly to
much higher proportion of related alleles compared to HLA-Cw
and -DRB1, depending on the region of interest (values ranged
from 0% in AUS to 40% in NAF for allele pairs differing by more
than 20 nucleotides, respectively). HLA-DPB1 contrasted with the
other loci as the proportion of sequence pairs that display 10 or
less than 10 divergent nucleotides within population groups varied
between 59.3% (SAF) and 92.9% (AUS). This can be related to the
fact that HLA-DPB1 exhibited the lowest pn and h in most
geographic regions (see File S2 and Figure 1A and B), and may
indicate a particularity of this locus with respect to balancing
selection, as shown by other kinds of evidence (see next section and
discussion).
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The results of the two tests of selective neutrality (Tajima’s D
and EW) are summarized in Table 2 and described in more details
in File S1. Almost all significant outcomes indicated an excess of
heterozygotes (i.e. D.0 for Tajima and Fobs,Fexp for EW),
suggesting balancing selection as the main cause of the deviation.
However, variable proportions of significant tests were found
among the different genes (HLA-B.-DQA1.-DRB1.-A.-
Cw.-DQB1.-DPB1 for Tajima’s D, and HLA-DQA1.-Cw.-
DRB1.-B.-DQB1.-A&-DPB1 for EW). Interestingly, we
observed higher proportions of significant outcomes with Tajima’s
D (64.3 to 96.7%) than with EW (1.8 to 48.3%) for all genes. The
discrepancy was even higher after Bonferroni’s correction for
multiple tests (Figure 3), with 0 to 5.9% of significant outcomes for
EW and 1.47 to 65.5% for Tajima’s D. Furthermore, for Tajima’s
D, class II loci, in particular -DQA1 and to a lesser extent -DQB1
and -DRB1, exhibited higher proportions of significant outcomes
than HLA-A, -B, -Cw and -DPB1. This pattern can be related to
the one described above for nucleotide diversity (pn).
We also detected a few significant cases showing D,0 with
Tajima’s test (2 populations at HLA-DPB1, including one which
remained significant after Bonferroni’s correction, and 1 popula-
tion at HLA-DQA1), and significant Fobs.Fexp with EW (6
populations at HLA-DPB1, 3 at HLA-A, 1 at HLA-B, and 1 at
HLA-DRB1).
Molecular genetic diversity within and among
geographic regions
WST values for populations grouped according to their
geographic location are given in Table 3 and File S3. At the
worldwide scale, HLA-DPB1 was the locus for which populations
were the most differentiated (WST=14.5%), followed by HLA-
DQA1 (13.1%), -DQB1 (8.8%), -A (8.2%), -DRB1 (7.4%), -Cw
(6.6%), and -B (6%). When TW, OCE and AME were excluded,
HLA-DPB1 was again the gene for which populations were the
most differentiated (WST=8.6%), but this time it was followed by -
Cw (4.5%), -B (4.1%), and -A, -DRB1, -DQB1 and -DQA1
(#3.8%).
A general tendency emerged for all loci at the regional scale,
with NAM, SAM, PAC and TW standing as the most diversified
regions in terms of population differentiations (File S3). On the
contrary, EUR, NAF and SWA were genetically very homoge-
neous, with similarly low WST values for all loci (yet significant,
except for NAF at HLA-A and -B and for SWA at HLA-DQA1,
but these two regions included only 2 populations each). The
remaining regions, i.e. SAF, NEA, CSEA and AUS, exhibited
intermediate WST values between these two extremes. These WST
values were always significant except for NEA at HLA-DQA1 (but
this group included only 3 populations).
Overall, WST values were very close to FSTs both at the
worldwide scale and in the different geographic regions (File S3),
yet with generally more marked variations in PAC, AUS, NAM
and SAM than in other population groups. Except in two cases
where differences can be explained by low sample sizes (non-
significant FST for SWA at HLA-DPB1 and non significant WST
for SWA at HLA-DQA1, these groups including 3 and 2
populations, respectively), the significance of these two indexes
was also similar.
The results of the hierarchical analyses of molecular genetics
variance (AMOVA) are given in Table 3. We found a significant
geographic structure (significant WCT’s) for all loci, but the
structure was stronger (WCT’s.WSC’s) for HLA-Cw, -DPB1,
-DQA1 and -DQB1 at the worldwide scale, and for HLA-A, -B,
-Cw, -DPB1 and -DQA1 when TW, OCE and AME were
excluded. No significant differences were observed with analyses of
genetic variance (ANOVA) based only on allelic frequencies (i.e.
Table 1. Summary of the population and DNA sequence data used in this study.
Locus SAF
1 NAF
1 EUR
1 SWA
1 NEA
1 SEA
1 PAC
1 AUS
1 NAM
1 SAM
1 OTH
1 All
1
HLA-A 1 2 282 0 32 4 84547 9 7
HLA-B 9 282 1 22 3 54547 9 0
HLA-Cw 8 041 5 22 0 44335 6 8
HLA-DRB1 9 91 8 1 0 82 2 731 2 71 1 0 6
HLA-DQA1 73 1 72 3 34 2 1 25 0 5 8
HLA-DQB1 10 13 22 5 5 6 7 2 12 7 0 89
HLA-DPB1 7 01 4 346 73840 5 6
Locus
Number of
individuals
2
Mean sample
size (SD)
Number of
sequences
3
Number of
nucleotide sites
4
HLA-A 12,224 126 (134.2) 414 (466) 546
HLA-B 11,440 127.1 (138.4) 755 (845) 546
HLA-Cw 8,263 121.5 (132.9) 231 (269) 546
HLA-DRB1 11,848 111.8 (115.8) 438 (497) 270
HLA-DQA1 5,398 93.1 (45.7) 33 (46) 249
HLA-DQB1 9,255 104 (54.5) 70 (87) 270
HLA-DPB1 4,911 87.7 (46.1) 121 (221) 264
1Number of populations.
2The total number of individuals included in the analyses is around 23,500, as many individuals have been simultaneously typed at several loci.
3Data loaded from the IMGT official database (release 2.13). In fact, the number of sequences used for the analyses is slightly higher (indicated within brackets) due to
the automated conversions to lower levels of resolution (e.g. from 6 to 4 digits) applied to the data, as explained in Materials and methods.
4Exons 2 and 3 for class I genes, exon 2 for class II genes.
doi:10.1371/journal.pone.0014643.t001
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PLoS ONE | www.plosone.org 3 February 2011 | Volume 6 | Issue 2 | e14643Figure 1. HLA genetic diversity within populations. A) heterozygosity (h) and B) nucleotide diversity (pn) within populations grouped
according to their geographic location, at each locus under study. Only the regions represented by populations at every locus are illustrated on the
graphs. See File S2 for detailed values (means and standard deviations). Sub-Saharan Africa (SAF), Europe (EUR), Southwest Asia (SWA), Northeast Asia
(NEA), Southeast Asia (SEA), , Pacific (PAC), Australia (AUS), North America (NAM), and South America (SAM). See Supporting Information S1 for the list
of populations included in each region.
doi:10.1371/journal.pone.0014643.g001
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not shown).
Correlation between genetics and geography
Correlation coefficients between geographic and genetic
distances based on the molecular approach were computed both
for all populations, and for each geographic region taken
separately (Table 3 and File S3). We also estimated these
coefficients for all regions minus TW, OCE and AME, because
we expected a low correlation with geography in the latter regions
due to high population divergence resulting from genetic drift,
which may reduce the correlation existing at the global scale.
Moreover, correlation coefficients within regions were only
computed for regions represented by a minimum of 5 populations
in the dataset. This criterion was chosen so as to avoid, on the one
hand, a too drastic reduction of the number of regions analyzed,
and the computation of meaningless correlation coefficients on the
other hand.
Both at the worldwide scale and when excluding TW, OCE and
AME, correlation with geography was significant for all genes and
reached intermediate to high values (e.g. r=0.167 for HLA-B and
r=0.468 for HLA-DQB1 worldwide, respectively). However,
geography seemed to be a better predictor of the genetic structure
when TW, OCE and AME were excluded, as in this case
correlation with geography was higher at all loci except HLA-
DQA1 and -DQB1. Correlation between genetics and geography
was usually lower within regions. This may be the consequence of
reducing the sets of populations at this geographic scale, lessening
the power of the statistical test, but may also reflect a variable
impact of geography among regions in shaping HLA genetic
profiles. Yet, except for SEA and NAF (AUS was not tested
because of insufficient data), correlation with geography was
significant for at least one HLA gene in every geographic region.
In SEA, a significant correlation was observed when populations
were subdivided into CSEA (at HLA-Cw) and TW (at HLA-B and
-Cw), respectively.
The correlation between genetics and geography was also
significant at the worldwide scale (both when considering all
populations and when excluding TW, OCE and AME) when
genetic distances were computed according to the allelic approach
(results not shown).
Differences in genetic distances between the molecular
and the allelic approaches
At the regional scale, however, a few differences were observed
between the molecular and the allelic approaches. Indeed,
correlation coefficients were significant in PAC at HLA-B, SAM
at HLA-DQA1, and SWA and EUR at HLA-DRB1 with the
molecular but not with the allelic approach, and the reverse
situation was observed in SEA at HLA-A, SWA at HLA-B, EUR
and NAM at HLA-DQA1, and NAF and SAM at HLA-DQB1.
Actually, some populations showed a majority of greater genetic
distances to the other populations when using the molecular
approach, while others showed a majority of lesser genetic
distances (Figure 4 and File S4). Two such examples are given
on Figure 5, where genetic distances based on molecular data are
Table 2. Tajima’s D and Ewens-Watterson (EW) tests of selective neutrality at each of the seven HLA loci analyzed.
Tajima
Locus n D,0
a %
b D.0
a %
b
A 97 0 (0) 0 (0) 86 (5) 88.7 (5.2)
B 90 0 (0) 0 (0) 87 (5) 96.7 (5.6)
Cw 68 0 (0) 0 (0) 57 (1) 83.8 (1.47)
DRB1 106 0 (0) 0 (0) 98 (12) 92.5 (11.3)
DQA1 58 0 (0) 0 (0) 54 (38) 93.1 (65.5)
DQB1 89 1 (0) 1.1 (0) 72 (18) 80.9 (20.2)
DPB1 56 2 (1) 3.6 (1.8) 36 (3) 64.3 (5.4)
Ewens-Watterson
Locus n Fobs.Fexp
a %
b Fobs,Fexp
a %
b
A 97 3 (0) 3.1 (0) 15 (2) 15.5 (2.1)
B 90 1 (0) 1.1 (0) 21 (0) 23.3 (0)
Cw 68 0 (0) 0 (0) 28 (4) 41.2 (5.9)
DRB1 106 1 (0) 0.9 (0) 27 (2) 25.5 (1.9)
DQA1 58 0 (0) 0 (0) 28 (1) 48.3 (1.7)
DQB1 89 0 (0) 0 (0) 19 (1) 21.3 (1.1)
DPB1 56 6 (0) 10.7 (0) 1 (0) 1.8 (0)
n: number of populations.
a: number of significant outcomes at the 5% level, and after Bonferroni’s correction for multiple tests within brackets.
b: proportion of significant outcomes at the 5% level, and after Bonferroni’s correction for multiple tests within brackets.
doi:10.1371/journal.pone.0014643.t002
Figure 2. Distributions of pairwise differences between HLA sequences (mismatch distributions). Average mismatch distributions within
populations grouped according to their geographical location, at each HLA locus under study. Histograms at the top-right indicate the proportion of
allele pairs with 0, 1–10, 11–20, 21–30, 31–40 and more than 40 nucleotides of divergence within each group of populations.
doi:10.1371/journal.pone.0014643.g002
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different loci (HLA-B and -DRB1) and where the points
corresponding to the distances of two different populations
(Samoans and Lebanese Arabs, respectively) are highlighted. For
Samoans at HLA-B (Figure 5A), genetic distances were clearly
skewed toward higher values with the molecular approach than
with the allelic approach, whether the opposite situation was
observed for Lebanese Arabs at HLA-DRB1 (Figure 5B). Detailed
comparisons of distance matrices obtained with the molecular and
allelic approaches (Figure 4 and File S4) showed that HLA-DQA1
was the only locus for which genetic distances were generally
underestimated with the allelic approach when all populations
were considered together (i.e. column ‘‘All’’ in Figure 4 where
more than 60% of the populations exhibit a majority of higher
molecular than allelic distances for HLA-DQA1). On the contrary,
genetic distances were usually overestimated for HLA-A, -DRB1,
and -DPB1 with the allelic approach (i.e. ,30% of the populations
exhibit a majority of higher molecular than allelic distances). This
was also true but to a lesser extent for HLA-Cw (.40%), while
HLA-B and -DQB1 were close to equality between the two
approaches (about 50%). At the regional scale, a general pattern
emerged (Figure 4). In TW, PAC, NAM and SAM, genetics
distances between populations tended to be higher at most loci
when molecular distances between alleles were considered, while
the opposite situation was observed for SAF, NAF, EUR, SWA
and CSEA, where genetic distances were commonly overestimated
on the sole basis of allelic frequencies.
These distance differences may explain why, in some regions
and for some loci (i.e. the ten cases listed above), the molecular and
allelic approaches differed in the significance of the correlation
with geography.
Table 3. Molecular genetic diversity indexes among populations (WST), within geographic groups (WSC) and among geographic
groups (WCT) and correlation coefficients between genetic and geographic distances (r) in all populations taken together and when
excluding TW, OCE and AME, at each HLA locus under study.
All populations
Locus n WST (%) r N WCT (%) WSC (%)
A 97 (92) 8.16 *** 0.184 *** 11 3.5 *** 5.07 ***
B 90 (85) 5.95 *** 0.167 *** 11 2.6 *** 3.67 ***
Cw 68 (63) 6.61 *** 0.226 *** 10 3.89 *** 3.11 ***
DRB1 106 (105) 7.43 *** 0.305 *** 9 9.29 *** 6.2 ***
DQA1 58 13.13 *** 0.396 *** 10 10.58 *** 4.16 ***
DQB1 89 8.84 *** 0.468 *** 10 5.38 *** 4.15 ***
DPB1 56 14.49 *** 0.329 *** 11 3.62 *** 4.22 ***
All populations minus TW, OCE and AME
Locus n WST (%) r N WCT (%) WSC (%)
A 54 3.84 *** 0.24 *** 6 2.29 *** 2.03 ***
B 50 4.08 *** 0.253 *** 6 2.62 *** 1.94 ***
Cw 34 4.54 *** 0.326 *** 5 3.19 *** 1.87 ***
DRB1 60 3.76 *** 0.431 *** 5 5.63 *** 4.17 ***
DQA1 35 3.45 *** 0.277 *** 6 2.3 *** 1.85 ***
DQB1 61 3.7 *** 0.32 *** 6 1.3 *** 2.69 ***
DPB1 34 8.59 *** 0.464 *** 6 1.84 *** 2.24 ***
n: number of populations; N: number of geographic groups; ***: P,0.001.
In a few cases, because a precise geographic location was not available for some populations, the number of populations studied (n) was different for r calculations, as
indicated within brackets. WST and r values for each different geographic group are given in File S3. OCE (Oceania) includes PAC and AUS; AME (the Americas) includes
NAM and SAM.
doi:10.1371/journal.pone.0014643.t003
Figure 3. Tests of selective neutrality. Percentages of significant
outcomes for Tajima’s D statistic and Ewens-Watterson test after
Bonferroni’s correction, at each locus under study (ordered according to
their location on chromosome 6, from telomere to centromere).
doi:10.1371/journal.pone.0014643.g003
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In this study, nucleotide diversity in PBR coding exons of HLA
genes was extensively analyzed for a dataset of 2,062 sequences in more
than 23,500 individuals from about 200 human populations spread
worldwide. To our knowledge, this is the first time that nucleotide
variability within the MHC is used to analyze human genetic diversity
on such a large dataset. Indeed, the information on HLA nucleotide
sequences has mostly been studied to discover the evolution of this
multigenic family [11,12,13,14,15,16,17,18,32,33,34], and to under-
stand its functionality [35,36,37]. As DNA sequences represent the
highest possible level of resolution available for studying the
polymorphism of these genes (with amino-acid sequences to whom
they are directly related), it should bring more insights and information
than the common approach which consists in comparing HLA alleles
on the basis of their frequencies, without acknowledging for their
molecular divergence. Currently, the availability of databanks
containing population samples already screened to reduce typing
a m b i g u i t i e s[ 2 6 ] ,a sw e l la st h ed e v e l o p m e n to fp r o g r a m sa l l o w i n gf o r
an optimal treatment of ambiguous cases to estimate allele frequencies
[27,28,29,30], have allowed to undertake this study, and to include this
informationwith more confidence.Of course, westillhadtostatistically
resolve remaining typing ambiguities in the data, update the allele
names to the successive nomenclature changes, and work with missing
data in the nucleotide sequences to obtain comparable DNA sequences
for all alleles detected in the population data (i.e. formatting the DNA
sequences of the alleles not existing anymore in the current sequence
alignments following their split into many synonymous variants, with
names extending from a 4-digits nomenclature to 6 or more digits).
Furthermore, we limited our analyses to the PBR coding exons of HLA
genes, and we had to assume the absence of recessive data (commonly
known as ‘‘blank’’) by considering all apparent homozygotes as true
homozygotes. However, thanks to the development of molecular
typing methods, the presence of blank alleles within HLA data has
been greatly reduced (frequencies are generally observed well below
5%) compared to serological typings, where blank could reach
frequencies higher than 30% for the HLA-Cw locus [38,39]. Thus,
although it is probable that the above assumption might cause some
b i a s e si nt h er e s u l t so ft h ep r e s e n ts t u d y ,w ee x p e c tt h e mt ob em i n i m a l .
The first objective of this study was to determine whether the
molecular profiles of HLA genetic diversity among human populations
(the molecular approach) were congruent or not with those based only
on frequency data for the same polymorphism (the allelic approach)
[19,20,22,24,25,40,41,42,43,44,45,46,47,48,49,50]. Our results sug-
gest that this is the case at the global scale. Indeed, we find a high and
significant correlation between genetics and geography for all HLA
genes, both when all populations are considered and when particularly
divergent regions are excluded (i.e. TW, OCE and AME). Correlation
with geography is lower in these latter regions where populations are
more differentiated from each other, in close agreement with the works
cited above and our own analyses based on allelic frequencies.
Furthermore, a significant geographic structure is observed at all loci,
confirming the major role played by geography in shaping HLA
molecular variability among populations.
More detailed analyses performed at the regional scale,
however, gives fairly different results. When considering different
geographic regions and different HLA loci, we observe a total of
10 cases out of 40 (see Results) where taking into account
nucleotide information leads to a change of significance (i.e. gain
or loss) of the correlation coefficient between genetics and
geography. This indicates that the estimation of the genetic
distance between some populations closely depends on whether or
Figure 4. Summary of the comparisons of Reynolds genetic distance matrices between the molecular and allelic approaches.
Percentage of populations exhibiting a majority of higher Reynolds genetic distances computed with the molecular approach compared to Reynolds
genetic distances computed with the allelic approach (see ‘‘Statistical analyses’’ in Materials and Methods for the definition of the two approaches)
within geographic regions, at each locus under study. The detailed comparisons of Reynolds matrices are given in File S4. Percentages were only
computed for regions including at least 5 populations (n$5).
doi:10.1371/journal.pone.0014643.g004
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instance, Amerindian, Oceanian and Taiwanese populations are
generally more distantly related to other populations if one weights
the genetic distance by the molecular distance between their
alleles, while the opposite situation is observed for Europeans,
continental Asians and Africans (Figure 4). This is indirect
evidence that despite the fact that lower numbers of alleles are
usually detected in the former group of populations compared to
the ones in Europe, Africa and continental Asia, these alleles are
highly divergent in the PBR exons, which is probably a result of
some functional constraints (see below). On the other hand, due to
the complexity of the HLA polymorphism, the changes towards
either greater or lesser genetic distances seem hardly predictable
for a given population as they vary among loci and also within
geographic regions (File S4). As a consequence, to analyze
systematically the DNA sequence variation of HLA alleles in
population studies may become essential for detailed genetic
comparisons among populations.
Our second objective was to investigate the molecular evolution
of the HLA polymorphism by comparing the molecular profiles of
populations to those depicted on the basis of allelic frequencies.
Here, we were mainly interested by the potential effects of
evolutionary mechanisms such as balancing selection and gene
conversion on the patterns of HLA molecular variability,
compared to the influence of demographic factors such as gene
flow and genetic drift. While we observe a reduced genetic
diversity in TW, OCE and AME (explained by demography) both
at the molecular and allelic levels, HLA-Cw exhibits a singular
pattern. Indeed, for this locus, mean values of nucleotide diversity
are roughly similar in TW, OCE and AME and in EUR, NAF,
SAF, SWA, NEA and CSEA. As HLA-Cw is the last HLA gene
which was characterized at the DNA level, its nucleotide diversity
may currently not be as well described as for the other genes.
However, a more likely explanation is that HLA-Cw evolves under
specific mechanisms compared to other HLA genes. Actually,
HLA-Cw molecules are exposed to fewer pathogenic pressures, in
relation to their lower cellular expression than other class I
molecules [51]; however, they are also the main KIR ligands and a
co-evolution of both polymorphisms is a likely hypothesis [52]. For
instance, disease studies and population genetics analyses have
reported a significant correlation (either positive or negative)
between the frequencies of HLA-Cw alleles and some KIR genes
(see [53,54] and references therein). In addition, HLA-Cw has a
more recent origin than other class Ia genes (i.e. classical class I
genes), as it is thought that the Cw and B loci shared a common
ancestor before the speciation of great apes, but after divergence of
apes and Old World monkeys [11,55]. As a consequence, HLA-
Cw had less time to accumulate polymorphism within its DNA
sequences than HLA-A and -B, which might be related to our
results on nucleotide diversity (Figure 1B) and distributions of
pairwise differences between sequences (Figure 2).
Although explainable by demography, the drop of genetic
diversity in many aboriginal populations is intriguing in the light of
the crucial functions played by HLA genes in the immune
surveillance of our organism. Indeed, reduced allele subsets, as
those observed in several populations, could affect in some way the
overall range of peptide binding specificity. In this respect, relevant
results emerge from the mismatch distributions (Figure 2). A
majority of alleles are distantly related among each other in all
geographic regions and at all loci except HLA-DPB1 and (to a
much lesser extent) -DQB1. This pattern may be the consequence
of balancing selection in the form of asymmetric heterozygous
advantage [56], where individuals carrying distantly related alleles
would benefit from a better immunological protection than
homozygous ones [57,58,59]. Natural selection favoring function-
ally effective HLA phenotypes would thus explain why populations
with reduced HLA genetic diversity may survive, which is in
agreement with two previous studies focusing on Amerindians
[40,60]. Of course, our approach is based on the assumption that
alleles greatly differing at the DNA level in PBR coding exons
cover a larger antigenic repertoire than closely related ones, which
has to be confirmed. The fact that HLA-DPB1 exhibits a distinct
profile than other classical HLA genes is another support to this
hypothesis, as this gene evolves (almost) neutrally [49,50,61,62]. A
recent theory of MHC evolution called Associative Balancing
Complex (i.e. ABC), where polymorphism in immune genes is
maintained both by epistasis among loci and purifying selection
against recessive deleterious mutations located nearby MHC loci
[63,64], has been shown (with simulated data) to result in large
differentiations between extant alleles. Thus, ABC evolution might
also explain the shape of the mismatch distributions observed for
classical HLA genes. Furthermore, ABC can act alongside
balancing selection, as both evolutionary forces are not mutually
exclusive.
Yet, another molecular mechanism may also be involved in the
shape of the mismatch distributions observed for HLA genes.
Indeed, in addition to DNA substitutions, gene conversion has
been proposed as a putative mechanism in the generation of new
HLA alleles [57,65,66,67,68,69,70,71,72,73], even though its
precise role and molecular process in the evolution of the MHC
remain controversial [74]. However, several studies have shown
that recombination and gene conversion can affect the shape of a
sequence phylogeny and its related mismatch distribution in a
similar way as a demographic expansion [75,76,77,78,79], i.e.
resulting in star-like phylogenies and bell-shaped mismatch
distributions [80,81,82]. Thus, to better understand the possible
effect of gene conversion on the molecular profiles observed for
HLA genes, we tested for the presence of significant conversion
fragments within HLA sequence alignments using the GENE-
CONV program [83,84] (Table 4). In agreement with other
studies [74,85,86], HLA-B and HLA-DPB1 stand out as being the
most affected by gene conversion as they exhibit the highest
number of significant conversion fragments (611 and 99,
respectively, after correction for multiple tests by the BLAST
method). Other HLA genes exhibit fewer significant conversion
fragments after correction (HLA-DRB1.-A.-Cw.-DQA1) or
none (HLA-DQB1). Therefore, as HLA-B and -DPB1 are the
most prone to gene conversion but display very different mismatch
distributions, gene conversion alone does not explain the different
patterns observed for those genes. As suggested above, asymmetric
overdominant selection and/or ABC evolution must have played a
prominent role, even though the effects of recombination, gene
Figure 5. Plot comparisons of Reynolds genetic distance matrices in two populations. Plot comparisons of Reynolds genetic distance
matrices computed with either the molecular (X-axis) or the allelic (Y-axis) approach (see ‘‘Statistical analyses’’ in Materials and Methods for the
definition of the two approaches) in Samoans for HLA-B (A) and in Lebanese Arabs for HLA-DRB1 (B). The red squares represent the genetic distances
between the single out population and the other populations available in the databank at this locus. The blue circles represent the genetic distances
between each pair of populations at this locus, excluding the single out population. The black line on the plot indicates the equality of distance
between both approaches. The detailed comparisons of Reynolds matrices are given in File S4.
doi:10.1371/journal.pone.0014643.g005
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from each other and may have acted simultaneously [87].
We have shown (Figure 2) and mentioned above that for HLA-
DQB1, alleles are more related to each other than for HLA-A, -B,
-Cw, -DQA1 and -DRB1, but still much less than for HLA-DPB1.
For HLA-DQB1, the result might be related to selective pressures
acting on the generation of HLA-DQ heterodimers. Indeed, class
II HLA molecules are usually formed by any association of cis and
trans allelic products, except for HLA-DQA1 and -DQB1 where
particular allele combinations have been shown to lead to unstable
dimers [88,89]. HLA-DQB1 would have been submitted, then, to
some kind of purifying selection due to structural constraints on
DQ proteins and slowing down the rate of nucleotide divergence.
Further studies are needed to test this hypothesis, as the
assumption of co-evolution of HLA-DQA1 and HLA-DQB1 was
initially based on serological assignations of their alleles, and has
not yet been investigated in relation to DNA sequences.
To complement the results obtained for the mismatch
distributions, we tested putative departures from selective
neutrality by the Tajima’s D statistic and the Ewens-Watterson
(EW) test. Evidence for balancing selection is detected at all loci
except HLA-DPB1 for EW, but the level of selection appears to be
heterogeneous across the HLA region. HLA-B exhibits the highest
percentage of significant departures for Tajima’s D among the
seven loci (which can be related to its mismatch distributions
showing very high proportions of unrelated alleles), although we
do not detect any significant outcomes in EW after correction for
multiple tests. As some studies suggest that this locus is the most
selected one [90,91], we suspect that the apparent neutrality
indicated with EW test after correction is due to a lack of power of
this test, which is too conservative when the number of alleles is
high (HLA-B is by far the gene showing the greatest number of
alleles within populations, see File S1) and the sample size not
substantially increased [61]. As a matter of fact, the proportions of
Tajima’s significant outcomes observed at HLA-A, -B and -Cw are
also in agreement with a study based on pathogen-driven
balancing selection [51]. Among class II genes, HLA-DRB1
exhibits the highest percentage of rejections for Tajima’s D, closely
followed by HLA-DQA1, whereas HLA-DQB1 exhibits smaller
percentages of rejections for both tests, in contradiction with some
studies [49,62,92,93]. When taking into account correction for
multiple tests for Tajima’s D (Figure 3), class II genes, in particular
HLA-DQA1, exhibit at least tenfold higher proportions of
significant outcomes than class I loci and HLA-DPB1. This might
be related to the fact that HLA-DQA1 is the locus with the
smallest number of alleles within populations (mean value of 7.4
compared to values of 12.1 to 31.6 at other loci), and that selection
acts strongly on maintaining highly divergent sequences at
intermediate frequencies as some sort of compensation. Results
on EW (see hereafter), nucleotide diversity within populations
(Figure 1B) and mismatch distributions (Figure 2) are concordant
with this assumption.
Concerning EW, and in agreement with published results
[47,62] of which a recent survey on 497 populations spread
worldwide [50], HLA-Cw and -DQA1 show the highest
proportions of significant outcomes.
Most of the results are thus congruent with previously published
works, but, yet, some contradictions appear between Tajima’s D
and EW results and at HLA-DQB1 for EW. For the latter
discrepancies, the use of unequal datasets is a probable
explanation (i.e. there is an agreement on the significant rejects
of neutrality observed for HLA-DQB1, it is only the proportion
which do vary between our study and previous works and this is
clearly dependent on the number of populations analysed), while
we should keep in mind that Tajima’s D and EW tests do not
apply to the same source of variability. As a matter of fact, the
former statistic takes into account the nucleotide differences
between alleles, while the latter is only based on allelic frequency
distributions. Moreover, the outcomes of Tajima’s test may be
interpreted in different manners, i.e. either by demographic effects
or selection. In particular, a significant positive D may result from
balancing selection but also from a demographic contraction,
while a negative D value may be caused by purifying selection
against deleterious alleles or by a demographic expansion. In the
seven datasets presently studied, all significant rejects of D are
towards positive values, except for 3 cases (2 at HLA-DPB1 and 1
at -DQB1, see Table 2). In populations of small size like
Amerindians and Oceanians, a positive D value may be
Table 4. Testing for the presence of significant conversion fragments within HLA genes (ordered according to their location on
chromosome 6, from telomere to centromere) with the GENECONV program package.
Locus
Number of
sequences
Number of
nucleotide sites
1
Number of
polymorphic sites
2
Number of
significant
conversion
fragments (no
correction)
Number of
significant
conversion
fragments (BLAST
correction)
3
Number of
significant
conversion
fragments
(Bonferroni
correction)
4
HLA-A 414 546 157 23444 5 0
HLA-Cw 231 546 112 2145 2 0
HLA-B 755 546 160 102890 611 0
HLA-DRB1 438 270 90 19917 15 0
HLA-DQA1 33 249 45 179 1 0
HLA-DQB1 70 270 37 164 0 0
HLA-DPB1 121 264 43 2252 99 0
Computations are done with 0% of missing data allowed at each nucleotide site, and using all sequences described in the IMGT official database (release 2.13).
1Exons 2 and 3 for class I genes, exon 2 for class II genes.
2This represents the number of nucleotide sites used by the program for detecting putative conversion fragments.
3,4Number of fragments remaining significant after corrections for multiple tests. The BLAST correction is described as more powerful than Bonferroni’s correction by the
author of GENECONV.
doi:10.1371/journal.pone.0014643.t004
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balancing selection, and it is not possible to disentangle the effects
caused by both alternatives. At the opposite, most populations
included in our analyses (or populations from close geographic
areas) have been described as evolving under demographic
expansion on the basis of mitochondrial DNA data [76,79], and
thus negative D values were expected under neutral conditions.
The fact that D remains significantly positive in most populations
from Europe, Africa and continental Asia is a proof that balancing
selection is acting significantly on HLA genes and, in the same
process, conceals some of the effects of demographic factors.
Our results merely suggest the existence of fluctuating selection
across loci, but also over time at the human MHC. According to
some authors [94], Tajima’s test is more powerful to detect the
magnitude of selection acting on HLA genes, as it is better suited
to detect ancient traces of selection (history of species timescale)
than EW (history of populations timescale). The fact that we
observe higher proportions of significant outcomes at every locus
according to Tajima’s D sustains this assumption. In this context,
the singular profile exhibited by HLA-DPB1 can be discussed.
Indeed, as already stated, this gene is described as evolving under
neutrality, which is concordant with our results of the EW tests.
However, we detect a high percentage of significant outcomes
according to Tajima’s D, including 3 populations remaining
significant after correction for multiple tests. Our hypothesis is that
HLA-DPB1 presently evolves under neutrality, but retains ancient
traces of balancing selection within its nucleotide sequences. The
fact that strong evidences for balancing selection at some amino
acid sites within the b-1 domain of HLA-DPB1 molecules have
been previously identified brings support to this conclusion [92].
In addition to balancing selection, we find evidence for
directional selection in some populations. However, most of the
populations displaying negative D values and/or excess homozy-
gosity (i.e. Fobs.Fexp) are, or have been, prone to genetic drift (see
File S1 for details on outcomes for individual populations),
suggesting that demography and stochastic forces, rather than
directional selection in response to specific pathogens, are the
main factors behind these peculiar statistical results. A similar
situation was discussed in a previous study [95].
To conclude, this study presents a large scale survey of HLA
molecular polymorphism among and within human populations.
While our analyses support previous results on the global genetic
structure of human populations based on HLA allelic frequencies,
we show that taking into account the molecular divergence of
HLA DNA sequences leads to different patterns of genetic
relationships between populations at regional scales. Notably,
populations that are usually described as very distant genetically
from each other on the basis of their HLA frequency distributions
(e.g. Taiwanese aborigines, Pacific islanders and Amerindians) are
even more discriminated when one weights their genetic distances
with the nucleotide differences among alleles, while the opposite
pattern is observed for the other populations. Furthermore, our
investigation reveals new information on the putative mechanisms
involved in the evolution of HLA genes. For instance, we confirm
that balancing selection left a strong signature on intra-population
diversity profiles at most loci and is the main force acting on the
maintenance of HLA polymorphism, even though gene conversion
and/or recombination may also have some influence. Our analysis
of pairwise differences between HLA alleles indicates that
balancing selection acting on this system is asymmetric, i.e.
stronger for heterozygotes having molecularly distant alleles, even
in populations exhibiting a low level of internal diversity. In
addition, other kinds of selection (notably at HLA-Cw and
-DQB1, which exhibit peculiar profiles compared to other loci) are
not excluded. We also detect ancient traces of selection in DNA
sequences of the HLA-DPB1 locus, which was assumed to evolve
close to neutral conditions on the basis of allelic frequencies
distributions. Nonetheless, despite accumulating evidence of
natural selection acting on HLA and while some challenging
questions remain unanswered (e.g. the intensity and time frame of
balancing selection acting on HLA [94]), the history and
demography of populations still appear to be the strongest factors
lying behind their genetic differentiations. In this context, working
with nucleotide sequences from PBR neighboring exons and
introns, that may evolve more neutrally, could provide new
perspectives.
Materials and Methods
Population samples
Population data used in this study are mainly taken from the
database of the 12
th and 13
th International Histocompatibility
Workshops (IHWs) [48,96], completed with additional data from
published reports and from our own laboratory (Table 1). A total
of 97, 90, 68, 106, 58, 89 and 56 populations were gathered for
HLA-A, -B, -Cw, -DRB1, -DQA1, -DQB1 and -DPB1, respec-
tively. We allocated each of these populations to one of ten
geographic groups defined a priori by the IHWG-AHGD
component: North Africa (NAF), sub-Saharan Africa (SAF),
Europe (EUR), Southwest Asia (SWA), Northeast Asia (NEA),
Southeast Asia (SEA), Pacific (PAC), Australia (AUS), North
America (NAM), and South America (SAM); for SEA, we
sometimes distinguished the aboriginal populations of Taiwan
(TW, not including the Hakka and Minnan populations which are
descendent of early Chinese settlers in Taiwan and speak Sino-
Tibetan languages, while Taiwanese indigenous peoples speak
Austronesian languages) from the continental Southeast Asian
populations (CSEA); we also considered an additional category
called Other (OTH) for known admixed populations. This last
category was not taken into account in most analyses notably
because we lack precise geographic information on most
populations. Furthermore, we referred to Oceania (OCE) for
PAC and AUS taken together, and to America (AME) for NAM
and SAM taken together (see File S1 for population names,
geographic regions, references, sample sizes and more). Population
samples were selected according to two criteria: (1) being
characterized at the allelic level (i.e. having all alleles coded on
at least 4 digits), and (2) lacking typing uncertainties corresponding
to ambiguous allele groups. Indeed, currently used coding
techniques for HLA data often do not allow any distinction
between groups of alleles that are undistinguishable for a given
typing method and alleles that are usually discriminated from each
other, except in specific combinations. As a consequence, taking
into account ambiguous allele groups often leads to incongruous
estimated frequencies (i.e. subdividing the group results in sharing
the frequencies equally among all the alleles composing it). On the
other hand, samples with individuals showing ambiguities that
correspond to multiple possible genotypes were allowed because
such ambiguities can easily be treated by the Gene[rate] computer
programs. A maximum of 3 to 5 individuals genotyped at the
generic level (i.e. 2-digits typing) were allowed in samples of very
large size to avoid a drastic reduction in the number of populations
included in the analyses. Due to the use of different typing
strategies and to the heterogeneity of the data sources, the data
included in this study were submitted to automated scripts written
in GNU/Linux shell bash to check for the latest updates and
changes in the official WHO HLA Nomenclature (e.g. allele
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adopted in 2002).
While these quality standards were chosen to retain only the
best characterized population samples, assuring a solid basis for
subsequent statistical analyses, this may have lead to a relative
heterogeneity in the datasets used for this study. Drawbacks of this
kind are hardly avoidable when data are gathered from various
sources and have been characterized in a time span of several
years. However, two considerations lessen this problem; first,
despite variable numbers of populations from one locus to another,
a closer look at the geographic maps provided in File S1 shows
that the overall coverage of geographic areas is quite similar for the
seven datasets. This is particularly true among class I, and among
class II genes, respectively. Indeed, data were principally taken
from the 12
th and 13
th IHWs database, and, thus, as class I and
class II genes were mainly genotyped within the scope of the 13
th
IHW, and 12
th IWH, respectively, with some additional typings
provided by the 13
th IHW, population datasets overlap for HLA-
A, -B and -Cw on the one hand, and HLA-DRB1, -DQA1,
-DQB1 and -DPB1 on the other hand.
DNA sequences
A total of 2,062 DNA sequences for alleles of class I (exons 2
and 3) and class II (exon 2) loci were downloaded from the IMGT
official database (release 2.13) [10,97]. This version of the database
was chosen so as to be more recent than the genotyping data in
hand, thus providing reference DNA sequences for all the alleles
detected in the population samples used for this study. Yet,
additional sequence formatting was necessary for some of the
alleles, as described below. We restricted our analyses to the PBR
(Peptide Binding Region) coding exon(s) which are the most
polymorphic amongst HLA classical genes and which are screened
through most typing protocols (Table 1). As a matter of fact, the
PBR exons contain less undetermined positions within sequence
alignments than neighboring exons and introns, as alleles have
generally been fully sequenced for PBR before being processed to
the databank, whereas other DNA regions are often incompletely
described and are thus less reliable for sequence comparisons.
Because the population data used in this study were genotyped
during a time span of several years and with different typing
protocols, we used automated scripts written in GNU/Linux shell
bash to process HLA allele sequences at each possible level of
resolution (e.g. HLA-A*01, A*0101, A*010101 and A*01010101).
Indeed, whereas official sequence alignments include up-to-date
allelic characterization, the molecular resolution of alleles in
population data may vary (e.g. a population sample may contains
typings referring to A*0101 while this allele name is not anymore
listed in the sequence alignments following its splits into several 6
and 8 digits alleles, see hereafter). Basically, the scripts replace
nucleotides within sequence alignments by a ‘‘?’’ (i.e. an
undetermined nucleotide) for any polymorphic position between
two (or more) alleles that are to be grouped when converted back to
a lower level of resolution (e.g. a C to ? replacement at position 144
of exon 2 for HLA-A*01010101, A*01010102N, A*010102,
A*010103, A*010104, A*010106, A*010107 and A*010108, and
a G to ? replacement at the same position for HLA-A*010105,
respectively, when all these alleles are reduced to the sequence
corresponding to HLA-A*0101). This process increases the number
of indeterminations within the sequences, thus explaining why only
populations characterized at the allelic level (i.e. 4 or more digits)
were considered in this work. A maximum level of 5% missing data
at each nucleotide site within the sequence alignments was allowed
in the estimation of all molecular statistics used in this study,
meaning that sites above that threshold were discarded from the
analyses (see next section). For the sites below that threshold and
containing undetermined nucleotides, a ‘‘?’’ for a given allele was
considered as identical to any determined nucleotide (A,G,T,C) at
the same site for another allele. Note that the number of nucleotide
sites with less than 5% of missing data vary both among different
loci as well as for a given locus depending on the number of
populations considered in each analysis (e.g. population compari-
sonsat the worldwide scale or on subsets of populations defined on a
geographic criterion; analyses at the intra-population level).
Statistical analyses
All analyses done for this study were performed twice, once using
the nucleotide sequences of PBR exons (hereafter the ‘‘molecular
approach’’), and once using only the allelic frequencies (hereafter
the ‘‘allelic approach’’). For the molecular approach, a distance
matrix of pairwise differences among DNA sequences was
computed and was used to weight all molecular statistics, while all
alleles were considered as molecularly equidistant for the allelic
approach. We estimated allelic frequencies in each population with
an EM algorithm by using the Gene[rate] program allowing to take
multiple genotypes (i.e. typing ambiguities) into account [27,28,29].
Significant departures from selective neutrality were tested by
Tajima’s D statistic at the nucleotide level [98] and by Ewens-
Watterson’s (EW) test on allelic frequency distributions [99,100].
The distribution of pairwise nucleotide differences between HLA
alleles (i.e. mismatch distribution) was obtained for each population,
and average mismatch distributions were generated on groups of
populations defined on a geographic criterion. The distributions
were plotted to depict mean nucleotide divergences between alleles
within each population subset (i.e. geographic region). This allowed
exploring whether molecular distances between alleles were skewed
towards greater values, an expected pattern of asymmetric
balancing selection (i.e. heterozygous with highly divergent alleles
would be functionally advantaged because they would be able to
cover wider spectrums of pathogen’s peptides),or not. We estimated
HLA molecular genetic diversity at three levels: (1) within
populations by computing nucleotide diversity (pn) indices [101];
(2) among populations by computing WST fixation indices; (3) using
the analysis of molecular variance (AMOVA) hierarchical frame-
work to estimate both the diversity among populations within
geographic groups (WSC index) and the diversity between geo-
graphic groups (WCT index) [102]. HLA genetic diversity based on
allelic frequencies was estimated at these same levels with the
expected heterozygozity (h) [103], FST,F SC, and FCT indices [104],
respectively. Statistical significance of the fixation indices was tested
by the non-parametric permutation procedure implemented in the
Arlequin computer package [105], which permutes individual
genotypes among populations for WSC/FSC and WST/FST,o r
populations among groups for WCT/FCT. Coancestry coefficients
(i.e. Reynolds genetic distances), which are directly derived from
WSTso rF STs [106], and geographic distances based on the arc
length of a sphere and transformed to natural logarithms [107] were
computed between all pairs of populations. Correlation coefficients
between genetic and geographic distances were computed and
tested by a Mantel test [108] using the NTSYS software [109].
Reynolds distance matrixes obtained for the molecular and the
allelic approaches were compared using a script written with the R
statistical software (http://www.r-project.org/).
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